James S Scott

25PUBLICATIONS
93CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsPharmaceutical delivery technologiesMolecular targetsBiologically active moleculesCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jan 30, 2026
Discovery of AZD9750, an Orally Bioavailable Androgen Receptor Degrader for the Treatment of Prostate Cancer.

James S Scott, Laura Evans, Peter C Astles

|Jun 20, 2025
Discovery and Validation of a Novel Class of Necroptosis Inhibitors Targeting RIPK1.

Lior Soday, Chotima Seripracharat, Janine L Gray

|Nov 18, 2024
Property-based optimisation of PROTACs.

James S Scott, Iacovos N Michaelides, Markus Schade

|Jul 31, 2024
Discovery and <i>In Vivo</i> Efficacy of AZ-PRMT5i-1, a Novel PRMT5 Inhibitor with High MTA Cooperativity.

James M Smith, Bernard Barlaam, David Beattie

|Jul 30, 2024
Structural and Physicochemical Features of Oral PROTACs.

Markus Schade, James S Scott, Thomas G Hayhow

|Jul 11, 2024
Discovery of a Series of Orally Bioavailable Androgen Receptor Degraders for the Treatment of Prostate Cancer.

Sharan K Bagal, Peter C Astles, Coura Diène

Pageof 5